Sandoz Group AG
Research Sandoz Group AG (SDZ) on Bullrun: market cap CHF 31.28B, P/E 42.8, dividend yield 1.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSDZ
- ExchangeSW
- CountrySwitzerland
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyCHF
- Market capCHF 31.28B
- P/E42.8
- Dividend yield1.1%
- Financial periodFY2025
- RevenueCHF 11.16B
- Revenue growth7.4%
- Net incomeCHF 914.00M
- Free cash flowCHF 810.00M
- Gross margin47.4%
Valuation Snapshot
latest market cap is CHF 31.28B; P/E is 42.8; dividend yield is 1.1%.
About Sandoz Group AG
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms.
Frequently asked questions
What is Sandoz Group AG's market cap?
Sandoz Group AG's market capitalization is CHF 31.28B.
What is Sandoz Group AG's P/E ratio?
Sandoz Group AG's price-to-earnings (P/E) ratio is 42.8.
Does Sandoz Group AG pay a dividend?
Sandoz Group AG has a dividend yield of 1.1%.
What does Sandoz Group AG do?
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology,...